Your Cart ( 1 Item )

• Open-Label Evaluation of a Novel Skin Brightening System Containing 0.01% Decapeptide-12 in Combination With 20% Buffered Glycolic Acid for the Treatment of Mild to Moderate Facial Melasma
  June 2013 | Volume 12 | Issue 6 | Original Article | 106 | Copyright © June 2013
  Sandra P. Ramírez MD,^a Alfonso C. Carvajal MD,^b Juan C. Salazar MD,^c Gladys Arroyave MD,^d Ana M. Flórez MD,^e and Hector F. Echeverry MD^f
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs